ANIP ANI Pharmaceuticals, Inc.
$83.91
▼ 0.18%
58
Value
60
P/E22.18
57
P/B3.11
46
P/S2.16
60
EV/EBITDA8.63
75
Growth
83
Revenue Growth43.8%
100
EPS Growth436.5%
73
FCF Growth264.2%
74
Momentum
58
12-Month Return19.4%
61
3-Month Return3.0%
65
1-Month Return6.2%
65
RSI (14)59.69
68
50/200 MABearish
30
Profitability
48
ROE15.5%
54
ROA5.3%
40
Gross Margin69.1%
59
Operating Margin12.6%
38
Net Margin8.6%
40
FCF Yield6.7%
57
Risk
44
Beta0.46
55
60-Day Volatility32.7%
36
QScore Analysis